BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 16264989)

  • 1. Mechanisms of disease: Insights into the emerging role of signal transducers and activators of transcription in cancer.
    Haura EB; Turkson J; Jove R
    Nat Clin Pract Oncol; 2005 Jun; 2(6):315-24. PubMed ID: 16264989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT-1: a novel regulator of apoptosis.
    Stephanou A; Latchman DS
    Int J Exp Pathol; 2003 Dec; 84(6):239-44. PubMed ID: 14748743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signaling by STATs.
    Ivashkiv LB; Hu X
    Arthritis Res Ther; 2004; 6(4):159-68. PubMed ID: 15225360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic STAT Transcription Factors as Targets for Cancer Therapy: Innovative Strategies and Clinical Translation.
    Wang W; Lopez McDonald MC; Hariprasad R; Hamilton T; Frank DA
    Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signal Transducer and Activator of Transcription (STATs) Proteins in Cancer and Inflammation: Functions and Therapeutic Implication.
    Loh CY; Arya A; Naema AF; Wong WF; Sethi G; Looi CY
    Front Oncol; 2019; 9():48. PubMed ID: 30847297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of Angiogenesis by Non-Coding RNAs in Cancer.
    Su Z; Li W; Lei Z; Hu L; Wang S; Guo L
    Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38254660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct and biologically significant interactions of human herpesvirus 8 interferon regulatory factor 1 with STAT3 and Janus kinase TYK2.
    Yang Z; Xiang Q; Nicholas J
    PLoS Pathog; 2023 Nov; 19(11):e1011806. PubMed ID: 37983265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KSHV vIL-6 enhances inflammatory responses by epigenetic reprogramming.
    Inagaki T; Wang KH; Kumar A; Izumiya C; Miura H; Komaki S; Davis RR; Tepper CG; Katano H; Shimoda M; Izumiya Y
    PLoS Pathog; 2023 Nov; 19(11):e1011771. PubMed ID: 37934757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ErbB Signaling Network and Its Potential Role in Endometrial Cancer.
    Androutsopoulos G; Styliara I; Zarogianni E; Lazurko N; Valasoulis G; Michail G; Adonakis G
    Epigenomes; 2023 Oct; 7(4):. PubMed ID: 37873809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin regulates the LIN28B‑mediated JNK/STAT3 signaling pathway through miR‑140‑3p in subretinal fibrosis.
    Hua Z; Yang W; Li D; Cui Y; Shen L; Rao L; Zheng Y; Zhang Q; Zeng W; Gong Y; Yuan L
    Exp Ther Med; 2023 Nov; 26(5):528. PubMed ID: 37869644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of the biomarkers for aging and cancer? - Challenges and current status.
    Li D; Ju F; Wang H; Fan C; Jacob JC; Gul S; Zaliani A; Wartmann T; Polidori MC; Bruns CJ; Zhao Y
    Transl Oncol; 2023 Dec; 38():101783. PubMed ID: 37716258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CHAF1A promotes the proliferation and growth of epithelial ovarian cancer cells by affecting the phosphorylation of JAK2/STAT3 signaling pathway.
    Xia D; Xu X; Wei J; Wang W; Xiong J; Tan Q; Xue P; Wang H
    Biochem Biophys Rep; 2023 Sep; 35():101522. PubMed ID: 37575547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pomegranate-specific natural compounds as onco-preventive and onco-therapeutic compounds: Comparison with conventional drugs acting on the same molecular mechanisms.
    Rahman MM; Islam MR; Akash S; Hossain ME; Tumpa AA; Abrar Ishtiaque GM; Ahmed L; Rauf A; Khalil AA; Al Abdulmonem W; Simal-Gandara J
    Heliyon; 2023 Jul; 9(7):e18090. PubMed ID: 37519687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KSHV vIL-6 Enhances Inflammatory Responses by Epigenetic Reprogramming.
    Inagaki T; Wang KH; Kumar A; Izumiya C; Miura H; Komaki S; Davis RR; Tepper CG; Katano H; Shimoda M; Izumiya Y
    bioRxiv; 2023 Jul; ():. PubMed ID: 37503036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct human skeletal muscle-derived CD90 progenitor subsets for myo-fibro-adipogenic disease modeling and treatment in multiplexed conditions.
    Li A; Anbuchelvan M; Fathi A; Abu-Zahra M; Evseenko D; Petrigliano FA; Dar A
    Front Cell Dev Biol; 2023; 11():1173794. PubMed ID: 37143896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PROTAC'ing oncoproteins: targeted protein degradation for cancer therapy.
    Kelm JM; Pandey DS; Malin E; Kansou H; Arora S; Kumar R; Gavande NS
    Mol Cancer; 2023 Mar; 22(1):62. PubMed ID: 36991452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pan-cancer analysis reveals signal transducer and activator of transcription (STAT) gene family as biomarkers for prognostic prediction and therapeutic guidance.
    Cheng M; Liu Y; Guo Y; Li M; Xian S; Qin H; Yang Y; Qian W; Tang J; Lu Y; Yao Y; Zhang M; Jin M; Xu L; Huang R; Xu D
    Front Genet; 2023; 14():1120500. PubMed ID: 36968603
    [No Abstract]   [Full Text] [Related]  

  • 18. PAFR/Stat3 axis maintains the symbiotic ecosystem between tumor and stroma to facilitate tumor malignancy.
    Zhao D; Zhang J; Zhang L; Wu Q; Wang Y; Zhang W; Xiao Y; Chen J; Zhan Q
    Acta Pharm Sin B; 2023 Feb; 13(2):694-708. PubMed ID: 36873192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel archetype in cancer therapeutics: exploring prospective of phytonanocarriers.
    Yadav N; Singh D; Rawat M; Sangwan N
    3 Biotech; 2022 Nov; 12(11):324. PubMed ID: 36276448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships among microbiota, gastric cancer, and immunotherapy.
    Li Y; Huang X; Tong D; Jiang C; Zhu X; Wei Z; Gong T; Jin C
    Front Microbiol; 2022; 13():987763. PubMed ID: 36171746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.